Where does Curvo Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Curvo Medical, Inc. ranks #31,333 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Curvo Medical, Inc. hold?

Curvo Medical, Inc. holds 8 US utility patents granted between 2016 and 2020, spanning 2 technology areas.

What is Curvo Medical, Inc.'s Innovation Score?

Curvo Medical, Inc. has an Innovation Score of 23.1 out of 100 (11th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Curvo Medical, Inc.'s patent grant rate increasing or decreasing?

Curvo Medical, Inc.'s recent grant velocity is -86% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Curvo Medical, Inc.'s patents?

Curvo Medical, Inc.'s patents average 17.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Curvo Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Curvo Medical, Inc.

Q: What technology areas does Curvo Medical, Inc. focus on?

Curvo Medical, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 6 patents, ranking #1,115 of 3,490 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 2 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Curvo ranks #31,333 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 2 technology areas.

#31,333
of 49,997 US assignees by volume: 11th percentile
by Innovation Score (23.1/100): 17.5
avg claims per patent: -86%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R31333 · US Corporation #31,333 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #31,333/49,997
PHOTO-FINISH Creative Bio-Peptides
CPC-NARROW A61M · 2 areas
INNOV-THIN 23.1/100
CLAIMS-RICH 17.5 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -86% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Creative Bio-Peptides, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Curvo’s 23.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (33%) Velocity 0.0 pts (0%) Breadth 5.0 pts (22%) Claim depth 10.5 pts (45%)

Qualcomm Incorporated · highest

85
Curvo Medical · this assignee

23
3D Lighting… · lowest

7

What this shows Curvo's Innovation Score is 23.1/100 (11th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Curvo?

Each dot is one of Curvo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Curvo’s own 17.5 claims/patent is at or below the 18.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Curvo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Curvo's grants concentrate

Curvo Medical, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 75% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2018 (5 grants) versus a trough of 1 in 2016. By volume, Curvo sits between Creative Bio-Peptides, Inc. and Cyclomedia Technology B.V..

Creative Bio-pept…

8
Crisp Sensation H…

8
Cubility AS

8
Curegenix

8
Curza Global

8
Cyber Atomics

8
Cybin IRL

8
Cyclomedia Techno…

8
Curvo Medical ◀

8

What this shows Curvo holds 8 patents at rank #31,339, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Curvo

By rank, the assignees closest to #31,339 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Curvo's primary technology class.

Curvo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

23 11th percentile higher than 11% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Curvo Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	12.5%
2017	1	12.5%
2018	5	62.5%
2020	1	12.5%

Which technologies does Curvo Medical, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

A61B - DIAGNOSIS; SURGERY; Identification 2

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Curvo Medical, Inc.'s patent record in context - here's where to go next.

Curvo Medical, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 75% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #31,333 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Curvo Medical, Inc. against Creative Bio-Peptides, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 23.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.